ZLN-024
- Product Name
- ZLN-024
- CAS No.
- 723249-01-2
- Chemical Name
- ZLN-024
- Synonyms
- ZLN024;ZLN-024;ZLN-024 (ZLN024);ZLN024, 10 mM in DMSO;2-[[2-(2-Bromo-4-methylphenoxy)ethyl]thio]-pyrimidine;2-[2-(2-bromo-4-methylphenoxy)ethylsulfanyl]pyrimidine;Pyrimidine, 2-[[2-(2-bromo-4-methylphenoxy)ethyl]thio]-;Inhibitor,AMPK,AMP-activated protein kinase,inhibit,ZLN024,ZLN 024,ZLN-024
- CBNumber
- CB82729381
- Molecular Formula
- C13H13BrN2OS
- Formula Weight
- 325.22
- MOL File
- 723249-01-2.mol
ZLN-024 Property
- Boiling point:
- 443.3±35.0 °C(Predicted)
- Density
- 1.49±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO: soluble20mg/mL, clear
- form
- powder
- pka
- 0.12±0.33(Predicted)
- color
- white to beige
Safety
- Hazard Codes
- Xn
- Risk Statements
- 22-37/38-41
- Safety Statements
- 26-39
- WGK Germany
- 3
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Danger
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H318Causes serious eye damage
H335May cause respiratory irritation
- Precautionary statements
-
P280Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352IF ON SKIN: wash with plenty of soap and water.
N-Bromosuccinimide Price
- Product number
- SML0900
- Product name
- ZLN024
- Purity
- ≥98% (HPLC)
- Packaging
- 5mg
- Price
- $65.8
- Updated
- 2025/07/31
- Product number
- SML0900
- Product name
- ZLN024
- Purity
- ≥98% (HPLC)
- Packaging
- 25mg
- Price
- $424
- Updated
- 2022/05/15
- Product number
- 21644
- Product name
- ZLN024
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $96
- Updated
- 2024/03/01
- Product number
- 21644
- Product name
- ZLN024
- Purity
- ≥98%
- Packaging
- 10mg
- Price
- $160
- Updated
- 2024/03/01
- Product number
- 21644
- Product name
- ZLN024
- Purity
- ≥98%
- Packaging
- 25mg
- Price
- $330
- Updated
- 2024/03/01
ZLN-024 Chemical Properties,Usage,Production
Uses
ZLN024 is a useful chemical reagent.
Biological Activity
ZLN024 is an allosteric activator of AMPK hetero-trimers. The compound ZLN024 protects against dephosphorylation of Thr172, which is critical for activity, and antagonizes AMPK autoinhibition. ZLM024 improves glucose tolerance and lowers total cholesterol levels in db/db mice.
in vivo
C57BKS db/db mice are administered a 15 mg/kg/day dose of ZLN024 by daily gavage for 5 weeks; 250 mg/kg/day Metformin (Met) is used as a positive control. During the treatment period, there is no significant alteration in food intake and body weight compared with the vehicle group. After 4 weeks of treatment, ZLN024 improves glucose tolerance. ZLN024 reduces the fasting blood glucose by 15%. Liver tissue weight, triacylglycerol and the total cholesterol content are decreased[1].
IC 50
AMPK α2β2γ1: 0.13 μM (EC50); AMPK α1β1γ1: 0.42 μM (EC50); AMPK α2β1γ1: 0.95 μM (EC50)
ZLN-024 Preparation Products And Raw materials
Raw materials
Preparation Products
ZLN-024 Suppliers
- Tel
- 44-20819178-90 02081917890
- Fax
- (0)2080432064
- info@novachemistry.com
- Country
- United Kingdom
- ProdList
- 4381
- Advantage
- 58